CONTACT US

CORPORATE & U.S. HEADQUARTERS

New York
10 Hudson Yards
37th Floor
New York, NY 10001

RESEARCH & DEVELOPMENT HEADQUARTERS

San Diego
4760 Eastgate Mall
San Diego, CA 92121

INTERNATIONAL HEADQUARTERS

London
Two Pancras Square
Kings Cross, London,
N1C 4AG, UK

Select a country below to see contact information specific to each country.

Medical information:
T: +43 1928 4012
E: medinfo@interceptpharma.com

To report adverse events:
T: +43 1928 4012
E: drugsafety@interceptpharma.com

To report adverse events:
T: +32 (0) 24037219
E: drugsafety@interceptpharma.com

Side effects should be reported. Notification forms and information can be found at https://www.fagg.be/nl/bijwerkingen

Medical information:
T: +1 844-782-4278
E: medinfo@interceptpharma.com

To report adverse events:
T: +1 844-782-4278
E: drugsafety@interceptpharma.com

Medical information:
T: +353 144 75 196
E: medinfo@interceptpharma.com

To report adverse events:
T: +353 144 75 196
E: drugsafety@interceptpharma.com

Medical information:
T: +33 176 701 049
E: medinfo@interceptpharma.com

To report adverse events:
T: +33 130 087 281
E: pv-intercept@anticipsante.com

Or directly to the National Agency for the Safety of Medicines and Health Products at www.ansm.sante.fr

Medical information:
T: +353 144 75 196
E: medinfo@interceptpharma.com

To report adverse events:
T: +353 144 75 196
E: drugsafety@interceptpharma.com

Medical information:
T: +353 144 75 196
E: medinfo@interceptpharma.com

To report adverse events:
T: +353 144 75 196
E: drugsafety@interceptpharma.com

Adverse events should be reported. Reporting forms and information can be found at www.hpra.ie

Medical information:
T: +39 0236026571
E: medinfo@interceptpharma.com

To report adverse events:
T: +39 050 9134
E: pv@regulatorypharmanet.com

Adverse events must be reported according to the procedures indicated by the Italian Medicines Agency at http://www.aifa.gov.it/content/come-segnalare-una-sospetta-reazione-avversa

To report adverse events:
T: (+352) 2786 1461
E: drugsafety@interceptpharma.com

Adverse effects should be reported. The forms and information on this subject can be consulted on http://sante.public.lu/fr/prevention/medicaments-humains/surveillance-medicaments/index.html

To report an adverse event suspected to be drug related, please contact:

The Regional Pharmacovigilance Center of Lorraine

Or

The Pharmacy and Medicines Division of the Directorate of Health:

Medical information:
T: +353 144 75 196
E: medinfo@interceptpharma.com

To report adverse events:
T: +353 144 75 196
E: drugsafety@interceptpharma.com

Medical information:
T: +31 207 139 216
E: medinfo@interceptpharma.com

To report adverse events:
T: +31 207 139 216
E: drugsafety@interceptpharma.com

Please report side effects. Notification forms and information can be found on www.lareb.nl

To report adverse events:
T: +351 308 805 674
E: drugsafety@interceptpharma.com

Adverse events should be reported. Information and forms for reporting an adverse event potentially related to an Intercept drug can be found at http://www.infarmed.pt/web/infarmed/submissaoram

Medical information:
T: +34 914 194 970
E: medinfo@interceptpharma.com

To report adverse events:
T: +34 914 194 970
E: drugsafety@interceptpharma.com

Adverse effects must be notified. The notification forms and information can be found at www.notificaRAM.es

To report adverse events:
T: +41 44 580 05 79
E: drugsafety@interceptpharma.com

To report adverse events:
T: +44 330 100 3694
E: drugsafety@interceptpharma.com

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard

Medical information:
T: 1-844-782-4278
E: medinfo@interceptpharma.com

To report adverse events:
T: 1-844-782-4278
E: drugsafety@interceptpharma.com

You may also report directly to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch